Use of Noninvasive Biomarker Tests vs. FibroScan for Predicting Significant Fibrosis in Egyptian Pediatric Cancer Survivors with Chronic Hepatitis C Virus Infection

Dalia N Toaima, Fatma A Marzouk, Alaa El-Haddad, Aisha Elsharkawy, Gamal E Esmat, Manal H El-Sayed · 2026

Read Use of Noninvasive Biomarker Tests vs. FibroScan for Predicting Significant Fibrosis in Egyptian Pediatric Cancer Survivors with Chronic Hepatitis C Virus Infection by Dalia N Toaima, Fatma A Marzouk, Alaa El-Haddad, Aisha Elsharkawy, Gamal E Esmat, Manal H El-Sayed (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13591162.txt.

Description

Dalia Toaima and co-authors compare cheap blood scores against a scanner for grading liver scarring in young cancer survivors with hepatitis C, in a 2026 study. Egyptian children on chemotherapy face raised infection risk from transfusions and weak immunity. Fifty-one survivors with lasting infection, median age 13.5, joined the study at two Cairo centers.

Each child got a stiffness scan of the liver plus two blood-based scores, APRI and FIB-4. About one in five showed advanced scarring. Blood scores rose with stiffness, and APRI called advanced scarring more truly than FIB-4, with cut points of 0.86 and 0.52. The authors back both scores as stand-ins where scanners are scarce, with APRI first choice.

Catalog record

CREATORDalia N Toaima, Fatma A Marzouk, Alaa El-Haddad, Aisha Elsharkawy, Gamal E Esmat, Manal H El-Sayed
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE30 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13591162

Browse the full library · About the Tower of Babel